At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antivirals; Benzonitrile
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 20 Apr 2001 New profile
- 20 Apr 2001 Preclinical development for HIV-1 infections in USA (Unknown route)